Healthcare, biotechnology & medical AI Product
MammoScreen supports review of screening mammograms
Therapixel’s MammoScreen helps interpreting physicians identify and characterize suspicious regions on screening mammograms. The fifth version’s FDA record covers compatible digital mammography and breast tomosynthesis systems. [1][2]
What it does
The FDA cleared MammoScreen under K192854 on March 25, 2020. It cleared MammoScreen 5 under K260714 on June 26, 2026. [1][2]
Why it matters
The clearance documents show how a reading aid can add region markers and suspicion scores within an existing interpretation workflow. [1][2]
Who it’s for
The labeled users are physicians interpreting screening mammograms. [1][2]
Key dates
Where it fits
MammoScreen 5 provides image markers and suspicion scores and can incorporate compatible prior exams in the analysis. [1][2]
Limits and trade-offs
Each submission specifies its supported image types and systems. The software is a concurrent reading aid, and physicians interpret the study. [1][2]
Sources and verification
Catalog evidence checked How we verify records
- Primary source FDA 510(k) decision for MammoScreen (K192854)
- Primary source FDA 510(k) decision for MammoScreen® (5) (K260714)
Related profiles
Healthcare, biotechnology & medical AI
Sleep Analysis Module (SAM)
Neurotronics (Nihon Kohden)
The module estimates sleep time from a signal captured during its intended sleep-testing workflow.
Healthcare, biotechnology & medical AI
Heartvue.Proton
Heartvue.ai
It is software for analyzing cardiac MRI images within its documented intended-use scope.
Healthcare, biotechnology & medical AI
ThinkSono Guidance
ThinkSono
Provides guidance during acquisition of lower-extremity compression ultrasound images for review by healthcare professionals.